MedTrace Logo

Measuring Bladder Volumes Scanning in the ICU

NCT03428113 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2019-04-03

No results posted yet for this study

Summary

ICU patients are at risk for catheter associated urinary tract infection. Frequently patients can't tell clinicians if they need to void if the catheter is removed. If clinicians know that an accurate volume measurement s of urine volume in the bladder can be obtained when the catheter is removed, catheters could be removed earlier and more frequently and thus possibly avoid an infection. For this study, measures with ultrasound (directly visualizing the bladder to measure), bladder scanner (partially blind measure with placement of scanner over the expected bladder location on the skin) and urine catheterized volume will be obtained. The investigators also want to know if the technology is user dependent. The study will include 2 levels of nurses RN and advanced practice RN (APRN) perform the bladder scanner. An APRN and MD will conduct the ultrasound. Ultrasound is technology primarily used by physicians but APRNs are using the technology technology more frequently. After these 4 measurements, the patient's nurse will perform an intermittent straight catheterization (catheter inserted, urine drained, and catheter removed) as the gold standard comparison.

Conditions

Interventions

OTHER

Bladder Volume Measurement bladder scanner RN

Measure Urine Volume with Bladder Scanner by RN

OTHER

Bladder Volume Measurement Ultrasound APRN

Measure Urine Volume with Point of Care Ultrasound by APRN

OTHER

Bladder Volume Measurement bladder scanner APRN

Measure Urine Volume with Bladder Scanner by APRN

OTHER

Bladder Volume Measurement Ultrasound MD

Measure Urine Volume with Point of Care Ultrasound by MD

OTHER

Intermittent Straight Catheterization

Measure Urine Volume with Intermittent Straight Catheterization

Sponsors & Collaborators

  • Washington University School of Medicine

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-04
Primary Completion
2018-07-31
Completion
2018-11-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03428113 on ClinicalTrials.gov